Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis following mismatched unrelated donor peripheral blood stem cell (PBSC) transplantation

被引:0
|
作者
Al Malki, Monzr M.
Bo-Subait, Stephanie
Logan, Brent
Olson, Janelle
Leckrone, Erin
Wu, Juan
Stefanski, Heather E.
Auletta, Jeffery J.
Spellman, Stephen R.
Malmberg, Craig
Shaffer, Brian C.
Modi, Dipenkumar
Khimani, Farhad
Gooptu, Mahasweta
Hamadani, Mehdi
Broglie, Larisa
Shaw, Bronwen E.
Devine, Steven Michael
Jimenez, Antonio Martin Jimenez
机构
[1] City Hope Natl Med Ctr, Duarte, CA USA
[2] NMDP, CIBMTR, Minneapolis, MN USA
[3] Med Coll Wisconsin, Div Biostat, Milwaukee, WI USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY USA
[5] Wayne State Univ, Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[6] H Lee Moffitt Canc Ctr & Res Inst, Dept Blood & Marrow Transplantat & Cellular Immun, Tampa, FL USA
[7] Dana Farber Canc Inst, Dept Hematol Oncol, Boston, MA USA
[8] Med Coll Wisconsin, CIBMTR, Milwaukee, WI USA
[9] Med Coll Wisconsin, CIBMTR, Dept Med, Milwaukee, WI USA
[10] Univ Miami, Sylvester Comprehens Canc Ctr, Miller Sch Med, Miami, FL USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
6503
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Allogeneic blood or marrow transplantation using haploidentical grandchildren donors and post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis
    Aljawai, Yosra M.
    Tsai, Hua-Ling
    Varadhan, Ravi
    Jones, Richard J.
    Imus, Philip H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (04) : 1469 - 1476
  • [12] Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation
    Mulroney, Carolyn M.
    Bilal Abid, Muhammad
    Bashey, Asad
    Chemaly, Roy F.
    Ciurea, Stefan O.
    Chen, Min
    Dandoy, Christopher E.
    Diaz Perez, Miguel A.
    Friend, Brian D.
    Fuchs, Ephraim
    Ganguly, Siddhartha
    Goldsmith, Scott R.
    Kanakry, Christopher G.
    Kim, Soyoung
    Komanduri, Krishna V.
    Krem, Maxwell M.
    Lazarus, Hillard M.
    Ljungman, Per
    Maziarz, Richard
    Nishihori, Taiga
    Patel, Sagar S.
    Perales, Miguel-Angel
    Romee, Rizwan
    Singh, Anurag K.
    Reid Wingard, John
    Yared, Jean
    Riches, Marcie
    Taplitz, Randy
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 194 (01) : 145 - 157
  • [13] Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
    Moiseev, Ivan S.
    Pirogova, Olga V.
    Alyanski, Alexandr L.
    Babenko, Elena V.
    Gindina, Tatyana L.
    Darskaya, Elena I.
    Slesarchuk, Olga A.
    Bondarenko, Sergey N.
    Afanasyev, Boris V.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (06) : 1037 - 1042
  • [14] Sirolimus and Post-Transplant Cyclophosphamide as Graft-versus-Host Prophylaxis in Patients Undergoing Matched Allogeneic Peripheral Blood Stem Cell Transplantation
    Ulrickson, Matthew
    Damghani, Faraz
    Yancey, Kristina
    Mohammed, Reeshma
    Davies, Kayla
    Rangan, Pooja
    De Padova, Nicolas
    Go, Aileen
    Kodali, Murali
    Nath, Rajneesh
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S450 - S451
  • [15] Post-Transplant High Dose Cyclophosphamide and Bortezomib As Graft-Versus-Host Disease Prophylaxis Following Allogeneic Hematopoietic Stem Cell Transplantation
    Bruno, Benedetto
    Cirrone, Frank
    Cole, Kelli
    Stocker, Kelsey
    Abdul-Hay, Maher
    Suarez-Londono, J. Andres
    Hochman, Tsivia
    Goldberg, Judith
    Al-Homsi, A. Samer Samer
    BLOOD, 2021, 138
  • [16] Disparities in Allograft Access in the Era of Post-Transplant Cyclophosphamide-Based Mismatched Unrelated Donor Transplantation
    Fingrut, Warren B.
    Scaradavou, Andromachi
    Barker, Juliet N.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (04)
  • [17] Abatacept/Tacrolimus or Abatacept/Tacrolimus/Post-Transplant Cyclophosphamide Are Safe and Highly Effective in Preventing Graft-Versus-Host Disease in Matched or Mismatched Donor Peripheral Blood Stem Cell Transplantation
    Vorobyev, Vladimir I.
    Subora, Anton Yu.
    Oleinik, Yulia A.
    Butaev, Lev S.
    Zherebtsova, Vera A.
    Kisilichina, Darya G.
    Ulyanova, Margarita A.
    Urnova, Evdokiya S.
    Sukhareva, Alena M.
    Bulusov, Matvei P.
    BLOOD, 2022, 140 : 7622 - 7623
  • [18] Impact of Graft Cell Dose on Outcomes after Matched Sibling Donor Peripheral Blood Stem Cell Transplantation with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
    Mushtaq, Muhammad Umair
    Kasaeian, Amir
    Chaudhary, Sibgha Gull
    Amin, Muhammad Kashif
    Anwar, Iqra
    Alemi, Hediyeh
    Khavandgar, Naghmeh
    Khalid, Muhammad Fareed
    Mcguirk, Matthew
    Abhyankar, Sunil
    Hamadani, Mehdi
    Shahzad, Moazzam
    BLOOD, 2024, 144 : 7379 - 7380
  • [19] Allogeneic Hematopoietic Stem Cell Transplantation After Solid Organ Transplantation in Patients With Hematologic Malignancies Managed With Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis
    Jang, Charley
    Hsu, Jingmei
    JOURNAL OF HEMATOLOGY, 2024, 13 (05) : 250 - 258
  • [20] Antithymocyte globulin plus post-transplant cyclophosphamide combination as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation for hematological malignancies
    Chen, Tzu-Ting
    Lin, Ching-Chan
    Lo, Wen-Jyi
    Hsieh, Ching-Yun
    Lien, Ming-Yu
    Lin, Che-Hung
    Lin, Chen-Yuan
    Bai, Li-Yuan
    Chiu, Chang-Fang
    Yeh, Su-Peng
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 525 - 533